4//SEC Filing
Mathew Aby J. 4
Accession 0001628280-25-034682
CIK 0000834365other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 5:54 PM ET
Size
5.0 KB
Accession
0001628280-25-034682
Insider Transaction Report
Form 4
Mathew Aby J.
EVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-07-07$22.27/sh−536$11,937→ 352,582 total
Footnotes (1)
- [F1]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0001556355
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 5:54 PM ET
- Size
- 5.0 KB